Publication date: Oct 03, 2022 The study from the Cornell and Duke team analyzed several types of cancers using human tumor samples and detected up to one fungal cell for ... Read more

Publication date: Sep 30, 2022 Melanoma skin cancer is one of the most dangerous and life-threatening cancer. Exposure to ultraviolet rays may damage the skin cell’s DNA, which causes melanoma ... Read more

Publication date: Oct 01, 2022 Background: To precisely predict drug response and avoid unnecessary treatment have been urgent needs to be resolved in the age of melanoma immunotherapy. Deep learning ... Read more

Publication date: Sep 29, 2022 Importance: This is the first study to quantify the 2-year recurrence rate of non-melanoma skin cancers (NMSCs) treated with image-guided superficial radiation therapy (IGSRT) and ... Read more

Publication date: Sep 29, 2022 Developmental signaling pathways associated with growth factors such as TGFb are commonly dysregulated in melanoma. Here we identified a human TGFb enhancer specifically activated in ... Read more

Publication date: Oct 01, 2022 Thats why (patients) need to find a good support group, a good advocacy group. Since then, we’ve developed a new patient packet that we sent ... Read more

Publication date: Sep 30, 2022 A large meta-analysis found that surgical treatment was associated with a 6-month longer median overall survival compared to conventional chemotherapy. Small, uncontrolled, retrospective studies that ... Read more

Publication date: Sep 27, 2022 Background Immunotherapy represented by the programmed death-1 (PD-1)/ligand 1 (PD-L1) monoclonal antibodies has led tumor treatment into a new era. However, the low overall response ... Read more

Publication date: Sep 27, 2022 Last October, within the 2021 SMR congress, we held the inaugural Diversity in Science Session. The goal of the session was to discuss diversity, equity, ... Read more